Bifidobacterium longum AH1206
Bifidobacterium longum AH1206 has been studied for its ability to establish itself in the human gastrointestinal tract, including a 2016 randomized controlled trial examining colonization and its ecological impact on the resident microbiome. Animal model studies have examined regulatory T cell responses relevant to allergy and enteric bacterial infection. Human clinical research on this strain is limited to colonization dynamics. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 4 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 1 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
5 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
Source →Establishment of Bifidobacterium longum AH1206 in the human gastrointestinal tract and its ecological implications· Lincoln (University of Nebraska) · 2016
-
[2]
PMID 20067483 →Bacterial strain‐specific induction of Foxp3+ T regulatory cells is protective in murine allergy models· Clinical & Experimental Allergy · 2010